Literature DB >> 23438512

Phosphotyrosine profiling of NSCLC cells in response to EGF and HGF reveals network specific mediators of invasion.

Hannah Johnson1, Rebecca S Lescarbeau, Jesus A Gutierrez, Forest M White.   

Abstract

Growth factor signaling is deregulated in cancer and often leads to invasion, yet receptor tyrosine kinase signaling pathways driving invasion under different growth factor conditions are not well understood. To identify specific signaling molecules regulating invasion of A549 non-small cell lung carcinoma (NSCLC) cells downstream of the epidermal growth factor receptor (EGFR) and Met, quantitative site-specific mass spectrometric analysis of tyrosine phosphorylation was performed following epidermal growth factor (EGF) or hepatocyte growth factor (HGF) stimulation, at three different growth factor concentrations and at two time points. Through this analysis, the temporal and concentration dependent phosphorylation profiles were obtained for 131 and 139 sites downstream of EGF and HGF stimulation, respectively. To characterize the effect of these signaling network alterations, we quantified 3D cell migration/invasion through Matrigel. Partial least-squares regression (PLSR) analysis was performed to identify the tyrosine phosphorylation sites most strongly correlated with EGF and/or HGF mediated invasion. Potential common and specific signaling events required for driving invasion downstream of EGFR and Met were identified using either a combined or two independent PLSR models, based on the quantitative EGF or HGF data. Our data highlight the integration and compartmentalization of signaling required for invasion in cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23438512      PMCID: PMC3950895          DOI: 10.1021/pr301192t

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  41 in total

1.  Membrane-associated guanylate kinase proteins MPP4 and MPP5 associate with Veli3 at distinct intercellular junctions of the neurosensory retina.

Authors:  Heidi Stöhr; Laurie L Molday; Robert S Molday; Bernhard H F Weber; Bernd Biedermann; Andreas Reichenbach; Franziska Krämer
Journal:  J Comp Neurol       Date:  2005-01-03       Impact factor: 3.215

2.  Cysteine-rich protein 1 is regulated by transforming growth factor-β1 and expressed in lung fibrosis.

Authors:  Päivi M Järvinen; Marjukka Myllärniemi; Hester Liu; Henna M Moore; Outi Leppäranta; Kaisa Salmenkivi; Katri Koli; Leena Latonen; Arja M Band; Marikki Laiho
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

3.  Growth factors from murine sarcoma virus-transformed cells.

Authors:  J E de Larco; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

4.  Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules.

Authors:  Yi Zhang; Alejandro Wolf-Yadlin; Phillip L Ross; Darryl J Pappin; John Rush; Douglas A Lauffenburger; Forest M White
Journal:  Mol Cell Proteomics       Date:  2005-06-11       Impact factor: 5.911

5.  The role of annexin A2 in tumorigenesis and cancer progression.

Authors:  Noor A Lokman; Miranda P Ween; Martin K Oehler; Carmela Ricciardelli
Journal:  Cancer Microenviron       Date:  2011-03-05

6.  Quantitative analysis of HGF and EGF-dependent phosphotyrosine signaling networks.

Authors:  Dean E Hammond; Russell Hyde; Irina Kratchmarova; Robert J Beynon; Blagoy Blagoev; Michael J Clague
Journal:  J Proteome Res       Date:  2010-05-07       Impact factor: 4.466

7.  Tyrosine-phosphorylated epidermal growth factor receptor and cellular p130 provide high affinity binding substrates to analyze Crk-phosphotyrosine-dependent interactions in vitro.

Authors:  R B Birge; J E Fajardo; B J Mayer; H Hanafusa
Journal:  J Biol Chem       Date:  1992-05-25       Impact factor: 5.157

8.  Reactive oxygen species mediate Met receptor transactivation by G protein-coupled receptors and the epidermal growth factor receptor in human carcinoma cells.

Authors:  Oliver M Fischer; Silvia Giordano; Paolo M Comoglio; Axel Ullrich
Journal:  J Biol Chem       Date:  2004-04-29       Impact factor: 5.157

9.  Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells.

Authors:  V Brinkmann; H Foroutan; M Sachs; K M Weidner; W Birchmeier
Journal:  J Cell Biol       Date:  1995-12       Impact factor: 10.539

10.  Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor.

Authors:  L Naldini; K M Weidner; E Vigna; G Gaudino; A Bardelli; C Ponzetto; R P Narsimhan; G Hartmann; R Zarnegar; G K Michalopoulos
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

View more
  14 in total

Review 1.  A Fresh Look at the Structure, Regulation, and Functions of Fodrin.

Authors:  Jamuna S Sreeja; Rince John; Dhrishya Dharmapal; Rohith Kumar Nellikka; Suparna Sengupta
Journal:  Mol Cell Biol       Date:  2020-08-14       Impact factor: 4.272

2.  Differential response to ablative ionizing radiation in genetically distinct non-small cell lung cancer cells.

Authors:  Ayman Oweida; Zeinab Sharifi; Hani Halabi; Yaoxian Xu; Siham Sabri; Bassam Abdulkarim
Journal:  Cancer Biol Ther       Date:  2016-04-02       Impact factor: 4.742

3.  A Split-Abl Kinase for Direct Activation in Cells.

Authors:  Juan E Diaz; Charles W Morgan; Catherine E Minogue; Alexander S Hebert; Joshua J Coon; James A Wells
Journal:  Cell Chem Biol       Date:  2017-09-14       Impact factor: 8.116

4.  Quantitative targeted proteomic analysis of potential markers of tyrosine kinase inhibitor (TKI) sensitivity in EGFR mutated lung adenocarcinoma.

Authors:  Shivangi Awasthi; Tapan Maity; Benjamin L Oyler; Yue Qi; Xu Zhang; David R Goodlett; Udayan Guha
Journal:  J Proteomics       Date:  2018-04-13       Impact factor: 4.044

5.  Quantitative Phosphoproteomics Reveals Wee1 Kinase as a Therapeutic Target in a Model of Proneural Glioblastoma.

Authors:  Rebecca S Lescarbeau; Liang Lei; Katrina K Bakken; Peter A Sims; Jann N Sarkaria; Peter Canoll; Forest M White
Journal:  Mol Cancer Ther       Date:  2016-05-17       Impact factor: 6.261

6.  Quantitative Profiling of Protein Tyrosine Kinases in Human Cancer Cell Lines by Multiplexed Parallel Reaction Monitoring Assays.

Authors:  Hye-Jung Kim; De Lin; Hyoung-Joo Lee; Ming Li; Daniel C Liebler
Journal:  Mol Cell Proteomics       Date:  2015-12-02       Impact factor: 5.911

7.  Evaluation of phosphopeptide enrichment strategies for quantitative TMT analysis of complex network dynamics in cancer-associated cell signalling.

Authors:  Benedetta Lombardi; Nigel Rendell; Mina Edwards; Matilda Katan; Jasminka Godovac Zimmermann
Journal:  EuPA Open Proteom       Date:  2015-03-01

8.  A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma.

Authors:  Aneesha Radhakrishnan; Vishalakshi Nanjappa; Remya Raja; Gajanan Sathe; Vinuth N Puttamallesh; Ankit P Jain; Sneha M Pinto; Sai A Balaji; Sandip Chavan; Nandini A Sahasrabuddhe; Premendu P Mathur; Mahesh M Kumar; T S Keshava Prasad; Vani Santosh; Geethanjali Sukumar; Joseph A Califano; Annapoorni Rangarajan; David Sidransky; Akhilesh Pandey; Harsha Gowda; Aditi Chatterjee
Journal:  Sci Rep       Date:  2016-10-31       Impact factor: 4.379

9.  5'-Inositol phosphatase SHIP2 recruits Mena to stabilize invadopodia for cancer cell invasion.

Authors:  Charles V Rajadurai; Serhiy Havrylov; Paula P Coelho; Colin D H Ratcliffe; Kossay Zaoui; Bruce H Huang; Anie Monast; Naila Chughtai; Veena Sangwan; Frank B Gertler; Peter M Siegel; Morag Park
Journal:  J Cell Biol       Date:  2016-09-05       Impact factor: 10.539

10.  The HGF inhibitory peptide HGP-1 displays promising in vitro and in vivo efficacy for targeted cancer therapy.

Authors:  Lisha Chen; Chunlin Li; Yimin Zhu
Journal:  Oncotarget       Date:  2015-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.